MAURIZI, NICCOLO'
 Distribuzione geografica
Continente #
NA - Nord America 2.361
EU - Europa 1.625
AS - Asia 989
SA - Sud America 187
AF - Africa 28
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 5.195
Nazione #
US - Stati Uniti d'America 2.323
RU - Federazione Russa 578
PL - Polonia 302
SG - Singapore 269
IT - Italia 228
CN - Cina 208
BR - Brasile 155
HK - Hong Kong 149
IE - Irlanda 139
VN - Vietnam 129
SE - Svezia 125
KR - Corea 74
FR - Francia 60
DE - Germania 58
IN - India 48
GB - Regno Unito 39
JO - Giordania 31
FI - Finlandia 24
CA - Canada 19
ES - Italia 18
CH - Svizzera 15
AR - Argentina 14
JP - Giappone 12
ID - Indonesia 11
UA - Ucraina 11
MX - Messico 10
NL - Olanda 9
BD - Bangladesh 8
EC - Ecuador 8
IQ - Iraq 8
PK - Pakistan 7
RO - Romania 6
DO - Repubblica Dominicana 5
KE - Kenya 5
ZA - Sudafrica 5
MA - Marocco 4
PH - Filippine 4
TR - Turchia 4
AU - Australia 3
AZ - Azerbaigian 3
CO - Colombia 3
GH - Ghana 3
IL - Israele 3
LT - Lituania 3
NP - Nepal 3
AE - Emirati Arabi Uniti 2
AT - Austria 2
BE - Belgio 2
BG - Bulgaria 2
CI - Costa d'Avorio 2
CL - Cile 2
OM - Oman 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
UZ - Uzbekistan 2
VE - Venezuela 2
BJ - Benin 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CG - Congo 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
DK - Danimarca 1
DZ - Algeria 1
EG - Egitto 1
GE - Georgia 1
GT - Guatemala 1
HN - Honduras 1
IR - Iran 1
KW - Kuwait 1
LB - Libano 1
LK - Sri Lanka 1
MU - Mauritius 1
MY - Malesia 1
NG - Nigeria 1
NO - Norvegia 1
PE - Perù 1
PT - Portogallo 1
SA - Arabia Saudita 1
SC - Seychelles 1
SN - Senegal 1
SR - Suriname 1
TJ - Tagikistan 1
TN - Tunisia 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 5.195
Città #
Santa Clara 478
Ashburn 308
Warsaw 295
Singapore 197
Fairfield 174
Dublin 139
Hong Kong 121
Chandler 118
San Jose 83
Woodbridge 83
Seattle 78
Dallas 75
Seoul 73
Beijing 69
Wilmington 68
Cambridge 62
Houston 56
Lawrence 55
Altamura 52
Munich 41
Ann Arbor 38
Florence 35
Mumbai 35
Ho Chi Minh City 34
Los Angeles 34
Boston 30
Lauterbourg 30
Princeton 30
New York 28
Hanoi 27
Council Bluffs 25
The Dalles 25
Moscow 24
Buffalo 23
Turku 20
Shanghai 19
São Paulo 17
Hefei 16
Scandicci 16
Bern 14
San Diego 14
Dong Ket 12
Tokyo 12
Frankfurt am Main 10
Medford 10
Barcelona 9
Rome 9
Denver 8
Jakarta 8
Da Nang 7
Grottaglie 7
Siena 7
Toronto 7
Andover 6
Atlanta 6
Boardman 6
Brooklyn 6
Falls Church 6
Fontebuona 6
Guangzhou 5
Guayaquil 5
Kent 5
London 5
Milan 5
Montreal 5
Paris 5
Redondo Beach 5
Campi Bisenzio 4
Chicago 4
Dearborn 4
Nairobi 4
Norwalk 4
Orem 4
Poplar 4
Redmond 4
Salerno 4
San Francisco 4
Thái Nguyên 4
Accra 3
Baghdad 3
Baku 3
Barnet 3
Buenos Aires 3
Castelfiorentino 3
Caxias do Sul 3
City of London 3
Clifton 3
Guarulhos 3
Haiphong 3
Helsinki 3
Hải Dương 3
Imola 3
Johannesburg 3
Lahore 3
Livorno 3
Manchester 3
Querétaro 3
Rio de Janeiro 3
Santo Domingo 3
Stockholm 3
Totale 3.451
Nome #
"Tuscany Registry for sAdden Cardiac DEath": metodo per la creazione di un registro multicentrico per la gestione di eventi di morte improvvisa in età giovanile 468
Participation in thrill-seeking activities by patients with hypertrophic cardiomyopathy: Individual preferences, adverse events and physician attitude 226
Long-term Outcomes of Pediatric-Onset Hypertrophic Cardiomyopathy and Age-Specific Risk Factors for Lethal Arrhythmic Events 220
Clinical Course and Significance of Hypertrophic Cardiomyopathy Without Left Ventricular Hypertrophy 218
Sex-related differences in exercise performance and outcome of patients with hypertrophic cardiomyopathy 208
Intraoperative diagnosis of Anderson-Fabry disease in patients with obstructive hypertrophic cardiomyopathy undergoing surgical myectomy 200
Timing of invasive septal reduction therapies and outcome of patients with obstructive hypertrophic cardiomyopathy 190
Reversible dilated cardiomyopathy: into the thaumaturgy of the heart - Part 2 182
Cardiovascular screening in low-income settings using a novel 4-lead smartphone-based electrocardiograph (D-Heart®) 179
Efficacy and safety of dysopiramide in patients with obstructive hypertrophic cardiomyopathy 172
The electrocardiogram in the diagnosis and management of patients with hypertrophic cardiomyopathy 164
Association of Obesity with Adverse Long-term Outcomes in Hypertrophic Cardiomyopathy 161
Clinical and Molecular Aspects of Cardiomyopathies: Emerging Therapies and Clinical Trials 157
Early Diagnosis and Outcome in Patients With Wild-Type Transthyretin Cardiac Amyloidosis 156
Effectiveness of subcutaneous implantable cardioverter-defibrillator testing in patients with hypertrophic cardiomyopathy 155
Genetic basis of pediatric sarcomeric hypertrophic cardiomyopathy: impact on long term outcome 154
Age-dependent diagnostic yield of echocardiography as a second-line diagnostic investigation in athletes with abnormalities at preparticipation screening 152
Strength of clinical indication and therapeutic impact of the implantable cardioverter defibrillator in patients with hypertrophic cardiomyopathy 151
Cardiomyopathies in children – inherited heart muscle disease: Overview of hypertrophic, dilated, restrictive and non-compaction phenotypes 149
Predictive value of classic sudden death risk factors in pediatric-onset hypertrophic cardiomyopathy 149
Feasibility of a combined mobile-health electrocardiographic and rapid diagnostic test screening for chagas-related cardiac alterations 149
Extra long term follow up of the original tuscany cohort of patients with hypertrophic cardiomyopathy 146
Common presentation of rare cardiac diseases: Arrhythmias 139
Telemedicine cardiovascular screening program in low-income settings by smartphone based technology 136
Sudden cardiac death in cardiomyopathies: acting upon “acceptable” risk in the personalized medicine era 135
Prevalence of cardiac amyloidosis among adult patients referred to tertiary centres with an initial diagnosis of hypertrophic cardiomyopathy 134
Comparative analysis of a 4-lead portable smartphone-based versus standard 12-lead electrocardiograph for cardiovascular screening in low-income settings 128
Prevalence of subcutaneous implantable cardioverter-defibrillator candidacy based on template ECG screening in patients with hypertrophic cardiomyopathy 126
Exercise testing in hypertrophic cardiomyopathy: A pathophysiological goldmine with protean clinical implications 124
β-blockers: Their new life from hypertension to cancer and migraine 114
Lifetime Clinical Course of Hypertrophic Cardiomyopathy: Outcome of the Historical Florence Cohort Over 5 Decades 88
null 7
Totale 5.237
Categoria #
all - tutte 14.614
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.614


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202132 0 0 0 0 0 0 0 0 0 0 10 22
2021/2022211 5 8 17 7 4 11 10 18 19 15 34 63
2022/2023651 52 175 35 25 30 93 69 41 73 9 30 19
2023/2024264 6 23 30 11 13 60 16 61 5 13 15 11
2024/20251.499 64 166 111 244 408 172 25 77 48 42 65 77
2025/20261.634 196 218 160 218 202 62 241 77 97 120 43 0
Totale 5.237